Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 1 |
Descriptor
| Adolescents | 1 |
| Autism | 1 |
| Behavior Problems | 1 |
| Children | 1 |
| Drug Therapy | 1 |
| Interpersonal Competence | 1 |
| Intervention | 1 |
| Pervasive Developmental… | 1 |
| Pharmacology | 1 |
| Symptoms (Individual… | 1 |
Source
| Journal of Autism and… | 1 |
Author
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkCrutel, Véronique; Lambert, Estelle; Penelaud, Pierre-François; Albarrán Severo, Cristina; Fuentes, Joaquin; Rosier, Antoine; Hervás, Amaia; Marret, Stéphane; Oliveira, Guiomar; Parellada, Mara; Kyaga, Simon; Gouttefangeas, Sylvie; Bertrand, Marianne; Ravel, Denis; Falissard, Bruno – Journal of Autism and Developmental Disorders, 2021
There are currently no approved pharmacological treatments to improve social reciprocity and limit repetitive and rigid behaviors in autism spectrum disorder (ASD). We describe the design of two Phase III studies evaluating the efficacy/safety of bumetanide oral liquid formulation in ASD. These are international, multicenter, randomized,…
Descriptors: Autism, Pervasive Developmental Disorders, Children, Adolescents
